Keystone Financial Group I Bio, Inc. Transaction History

Keystone Financial Group

  • $274 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 11, 2021
SELL
$1.18 - $2.62 $14,986 - $33,274
-12,700 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$1.05 - $2.24 $866 - $1,848
-825 Reduced 6.1%
12,700 $13,000
Q3 2020

Nov 13, 2020
BUY
$1.7 - $6.41 $22,992 - $86,695
13,525 New
13,525 $27,000

About iBio, Inc.

IBIO Quotes by TradingView
  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Keystone Financial Group Portfolio

Follow Keystone Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email